An analysis of recent guidance and emerging best practices on counsel’s ethical duty to be technologically proficient, with a focus on counsel’s obligations in the context of e-discovery and ...

An expert Q&A on the legal, ethical, and practical considerations and emerging issues regarding judicial use of AI, including ...

Background Although multiple studies have offered self-collection for human papillomavirus (HPV)-based cervical screening in community settings, there are no randomised controlled trials (RCTs) that ...

Introduction The importance of conducting qualitative research alongside clinical trials of complex healthcare interventions is well established. There are various ways in which these two ...

Traditionally paper diaries are used to collect safety data in clinical trials, however electronic form of these paper diaries represent a paramount resource that could improve data quality, reduce ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

MoonLake Immunotherapeutics (MLTX) Securities Class Action: The complaint, filed in the U.S. District Court for the Southern District of New York, alleges that MoonLake and certain executives made ...

Selinexor-based regimens enhance T-cell activation in RRMM patients, without increasing inhibitory checkpoint molecules, indicating resistance is not due to T-cell exhaustion. Baseline protein ...

Protara Therapeutics (TARA) slipped ~6% in the premarket on Wednesday after posting interim data from a mid-stage trial for its lead candidate, TARA-002, in children with lymphatic malformations, a ...

Interim phase 3 trial data show that atacicept reduces proteinuria over 36 weeks in patients with IgA nephropathy. Patients with IgA nephropathy treated with atacicept experience substantial reduction ...